BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stanley TL, Grinspoon SK. GH/GHRH axis in HIV lipodystrophy. Pituitary 2009;12:143-52. [DOI: 10.1007/s11102-008-0092-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Pirmohamed M. Clinical management of HIV-associated lipodystrophy: . Current Opinion in Lipidology 2009;20:309-14. [DOI: 10.1097/mol.0b013e32832d3bb1] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
2 Brigante G, Diazzi C, Ansaloni A, Zirilli L, Orlando G, Guaraldi G, Rochira V. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution. European Journal of Endocrinology 2014;170:685-96. [DOI: 10.1530/eje-13-0961] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
3 Berryman DE, List EO. Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity. Int J Mol Sci 2017;18:E1621. [PMID: 28933734 DOI: 10.3390/ijms18081621] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
4 Brigante G, Riccetti L, Lazzaretti C, Rofrano L, Sperduti S, Potì F, Diazzi C, Prodam F, Guaraldi G, Lania AG, Rochira V, Casarini L. Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro. Mol Cell Endocrinol 2019;482:37-44. [PMID: 30543878 DOI: 10.1016/j.mce.2018.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sivakumar T, Mechanic O, Fehmie DA, Paul B. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. HIV Med 2011;12:453-62. [PMID: 21265979 DOI: 10.1111/j.1468-1293.2010.00906.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
6 Falutz J. Management of fat accumulation in patients with HIV infection. Curr HIV/AIDS Rep 2011;8:200-8. [PMID: 21739217 DOI: 10.1007/s11904-011-0087-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
7 Lagathu C, Cossarizza A, Béréziat V, Nasi M, Capeau J, Pinti M. Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. AIDS 2017;31 Suppl 2:S105-19. [PMID: 28471941 DOI: 10.1097/QAD.0000000000001441] [Cited by in Crossref: 61] [Cited by in F6Publishing: 35] [Article Influence: 12.2] [Reference Citation Analysis]
8 Zirilli L, Orlando G, Carli F, Madeo B, Cocchi S, Diazzi C, Carani C, Guaraldi G, Rochira V. GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls. European Journal of Endocrinology 2012;166:415-24. [DOI: 10.1530/eje-11-0829] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wilson JR, Brown NJ, Nian H, Yu C, Bidlingmaier M, Devin JK. Dipeptidyl Peptidase-4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women. J Am Heart Assoc 2018;7:e008000. [PMID: 29478970 DOI: 10.1161/JAHA.117.008000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Koethe JR, Lagathu C, Lake JE, Domingo P, Calmy A, Falutz J, Brown TT, Capeau J. HIV and antiretroviral therapy-related fat alterations. Nat Rev Dis Primers 2020;6:48. [PMID: 32555389 DOI: 10.1038/s41572-020-0181-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
11 Toribio M, Neilan TG, Awadalla M, Stone LA, Rokicki A, Rivard C, Mulligan CP, Cagliero D, Fourman LT, Stanley TL, Ho JE, Triant VA, Burdo TH, Nelson MD, Szczepaniak LS, Zanni MV. Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences. J Clin Endocrinol Metab 2019;104:6090-100. [PMID: 31393564 DOI: 10.1210/jc.2019-01096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
12 Toribio M, Neilan TG, Zanni MV. Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations. Curr HIV/AIDS Rep 2019;16:371-80. [PMID: 31482297 DOI: 10.1007/s11904-019-00458-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
13 Falutz J. Growth hormone and HIV infection: Contribution to disease manifestations and clinical implications. Best Practice & Research Clinical Endocrinology & Metabolism 2011;25:517-29. [DOI: 10.1016/j.beem.2010.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
14 Quin J. Diabetes and HIV. Clin Med (Lond) 2014;14:667-9. [PMID: 25468855 DOI: 10.7861/clinmedicine.14-6-667] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Palchetti CZ, Patin RV, Gouvêa ADFTB, Szejnfeld VL, Succi RCDM, Oliveira FLC. Body composition and lipodystrophy in prepubertal HIV-infected children. The Brazilian Journal of Infectious Diseases 2013;17:1-6. [DOI: 10.1016/j.bjid.2012.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Diazzi C, Brigante G, Ferrannini G, Ansaloni A, Zirilli L, De Santis MC, Zona S, Guaraldi G, Rochira V. Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients. Endocrine 2017;55:885-98. [PMID: 27730472 DOI: 10.1007/s12020-016-1133-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Rochira V, Guaraldi G. Growth hormone deficiency and human immunodeficiency virus. Best Pract Res Clin Endocrinol Metab 2017;31:91-111. [PMID: 28477736 DOI: 10.1016/j.beem.2017.02.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
18 Fiorenza CG, Chou SH, Mantzoros CS. Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol. 2011;7:137-150. [PMID: 21079616 DOI: 10.1038/nrendo.2010.199] [Cited by in Crossref: 145] [Cited by in F6Publishing: 136] [Article Influence: 12.1] [Reference Citation Analysis]
19 Mantzoros CS. W(h)ither metreleptin for lipodystrophy and the metabolic syndrome? Endocr Pract 2010;16:162-6. [PMID: 20350904 DOI: 10.4158/EP10038.ED] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
20 Herasimtschuk AA, Hansen BR, Langkilde A, Moyle GJ, Andersen O, Imami N. Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy. Clin Exp Immunol 2013;173:444-53. [PMID: 23701177 DOI: 10.1111/cei.12141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
21 Schulte-Hermann K, Schalk H, Haider B, Hutterer J, Gmeinhart B, Pichler K, Brath H, Dorner TE. Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients. J Infect Chemother 2016;22:248-53. [PMID: 26907935 DOI: 10.1016/j.jiac.2016.01.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
22 Kettelhut A, Bowman E, Funderburg NT. Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV. Curr HIV/AIDS Rep 2020;17:394-404. [PMID: 32535769 DOI: 10.1007/s11904-020-00509-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dudgeon WD, Phillips KD, Durstine JL, Burgess SE, Lyerly GW, Davis JM, Hand GA. Individual exercise sessions alter circulating hormones and cytokines in HIV-infected men. Appl Physiol Nutr Metab 2010;35:560-8. [PMID: 20725124 DOI: 10.1139/H10-045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Lewitt MS. The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity. Biochem Insights 2017;10:1178626417703995. [PMID: 28469442 DOI: 10.1177/1178626417703995] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
25 Steinman J, DeBoer MD. Treatment of cachexia: melanocortin and ghrelin interventions. Vitam Horm 2013;92:197-242. [PMID: 23601426 DOI: 10.1016/B978-0-12-410473-0.00008-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
26 Chantry CJ, Loomba-Albrecht LA. Conundrum of growth and childhood HIV infection. J Pediatr Gastroenterol Nutr 2014;59:424-5. [PMID: 24979480 DOI: 10.1097/MPG.0000000000000476] [Reference Citation Analysis]